ARTICLE

FindCenter AddIcon

Tripping on Iboga

By Daniel Pinchbeck — 1999

Over the last decades, iboga has developed a cult following in the United States and in Europe, where it is known as ibogaine. In the West, the psychedelic is being promoted as a potential one-shot cure for treating addiction to heroin and other drugs. Some researchers believe that ibogaine has the ability to "reset the switches" of addiction, freeing addicts from withdrawal symptoms and all drug cravings for up to six months.

Read on www.salon.com

FindCenter Post-Image

The Cost of Exclusion in Psychedelic Research

In the last two decades, researchers have started to reexamine psychedelics for their therapeutic potential. Though initial results seem promising, the research has a significant shortcoming: the lack of racial and ethnic diversity among research teams and study participants.

FindCenter AddIcon
FindCenter Post-Image

Psychedelic Psychotherapy Is Coming: Who Will Be Included?

A new study finds widespread exclusion of minorities in psychedelic research.

FindCenter AddIcon
FindCenter Post-Image

How Researchers and Advocates of Color Are Forging Their Own Paths in Psychedelic-Assisted Therapy

We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.

FindCenter AddIcon
FindCenter Post-Image

Study Finds Ketamine Can Help Patients Manage Depression and PTSD

Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.

FindCenter AddIcon
FindCenter Post-Image

Who Will Benefit From Psychedelic Medicine?

These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.

FindCenter AddIcon
FindCenter Post-Image

Psychedelics Shown to Ease the Effects of Racial Trauma

A recent study found that even a single positive psychedelic experience may ease mental health symptoms associated with racial trauma experienced by Black, Indigenous, and people of color (BIPOC).

FindCenter AddIcon
FindCenter Post-Image

The Emergence of a New Market: Psychedelic Science Conferences

Many are talking about the “commodification of psychedelics” or the “new psychedelic businesses” or “corporations”; however, this boom is affecting all areas of our field.

FindCenter AddIcon
FindCenter Post-Image

Seismic Sisters: Fighting Stigma of Psychedelics with Science - An Interview with Natalie Ginsberg, Policy and Advocacy Director at Multidisciplinary Association for Psychedelic Studies

Society has started to become more accepting of our work and MAPS’ goal of mainstreaming psychedelic medicine seems closer than ever to being achieved,” explains MAPS Policy and Advocacy Director Natalie Ginsberg, M.S.W., in an interview with Jessica Semaan of Seismic Sisters.

FindCenter AddIcon
FindCenter Post-Image

Beyond Death: The Science of the Afterlife

This question is more than a mind-bender. For thousands of years, certain people have claimed to have actually visited the place that, Saint Paul promised, “no eye has seen … and no human mind has conceived,” and their stories very often follow the same narrative arc.

FindCenter AddIcon
FindCenter Post-Image

What Your Body Has to Do With Social Change

Using somatics to explore trauma can help make authentic connection and collectivity more possible.

FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Journey